|
PRE-CONFERENCE
SHORT COURSE
INTRODUCTION TO RE-SEQUENCING OF HUMAN
GENES
CONFERENCE
SESSIONS:
 |
SETTING
THE STAGE FOR PHARMACOGENOMICS
|
|
PHASE
III & IV
|
|
POST-MARKETING
SURVEILLANCE AND RISK MITIGATION
STRATEGIES
|
|
KEYNOTE PRESENTATIONS |
|
|
The
conference sessions will be presented in
English, however individual headsets will be
provided for simultaneous French translation.
Download Complimentary Whitepaper
Pharmacodiagnostics and Rational Drug
Development
About Génome
Québec
Génome Québec is a private non-profit
organization whose mission is to reinforce Québec’s
innovation system in genomics by financing major
genomics research initiatives. The investments
of more than 400 million dollars since 2001 have
contributed to accelerate the discovery of new
applications, such as screening tests,
therapeutic tools in human health or new
environmental procedures in agriculture and
forestry. The funds invested by Génome Québec
come from the Ministère du Développement économique,
de l’Innovation et de l’Exportation of Québec,
the Government of Canada through Génome Canada
and from private partners. To find out more
about Génome Québec and genomics, visit its
Web site at www.genomequebec.com.
|
